Searchable abstracts of presentations at key conferences in endocrinology

ea0063p714 | Pituitary and Neuroendocrinology 2 | ECE2019

Low arginine vasopressin levels in patients with central diabetes insipidus is not associated with anaemia

Morin Benedict , Winzeler Bettina , Refardt Julie , Imber Cornelia , Fenske Wiebke , Sailer Clara , Holbro Andreas , Christ-Crain Mirjam

Background: Arginine vasopressin (AVP) is released upon osmotic stimulation or hypovolemia in order to maintain water balance. A recent study showed a role of AVP in haematopoiesis by stimulating red blood cell precursors, suggesting a higher risk of anaemia in patientis with AVP deficiency. The aim of this study was to explore the effect of low AVP levels in patients with central diabetes insipidus (cDI) and primary polydipsia (PP) on haemoglobin and the prevalence of anaemia...

ea0049ep942 | Pituitary - Clinical | ECE2017

Characteristics and 1-year follow-up of patients with profound hyponatremia due to primary polydipsia – a multicentre prospective observational study

Sailer Clara , Winzeler Bettina , Nigro Nicole , Suter-Widmer Isabelle , Arici Birsen , Bally Martina , Schuetz Philipp , Mueller Beat , Christ-Crain Mirjam

Introduction: Hyponatremia due to excessive fluid intake (i.e. primary polydipsia (PP)) is common. It may culminate in profound hyponatremia – carrying considerable risk of morbidity. However, data on patients with PP leading to hyponatremia is largely lacking. Herein, we describe the characteristics of polydipsic patients hospitalised with profound hyponatremia, and assess one-year outcomes.Method: In this prospective observational study, we includ...

ea0073aep465 | Pituitary and Neuroendocrinology | ECE2021

Hypothalamic-pituitary-adrenal axis activity in patients with primary polydipsia and healthy volunteers

Kuehne Jill , Sailer Clara , Ismael da Conceição , Refardt Julie , Christ-Crain Mirjam , Winzeler Bettina

BackgroundThe pathophysiology of primary polydipsia, a disorder with increased fluid intake, is poorly understood. A dysregulation in the hypothalamic-pituitary-adrenal axis (HPA) is speculated and arises mainly from research in patients witch a schizophrenia spectrum disorder but data is contradictory. The aim of this study was to investigate markers of HPA axis activity in patients with primary polydipsia compared to healthy controls.<p class="abst...

ea0073aep467 | Pituitary and Neuroendocrinology | ECE2021

The GLP-1 receptor agonist dulaglutide reduces fluid intake in primary polydipsia: A randomised controlled trial

Winzeler Bettina , Sailer Clara , David Coynel , Zanchi Davide , Vogt Deborah , Urwyler Sandrine , Refardt Julie , Christ-Crain Mirjam

BackgroundPrimary polydipsia, characterized by excessive fluid intake, carries the risk of water intoxication and hyponatremia, but treatment options are scarce. Glucagon-like peptide-1 (GLP-1) reduces appetite and food intake. In experimental models, they also play a role in thirst and drinking behavior. The aim of this trial was to investigate whether GLP-1 receptor agonists reduce fluid intake in patients with primary polydipsia.<p class="abstext"...

ea0099p315 | Pituitary and Neuroendocrinology | ECE2024

Validation of baseline laboratory levels and a novel probability score in the diagnosis of patients with suspected arginine vasopressin deficiency (Central Diabetes Insipidus)

Atila Cihan , Chifu Irina , Drummond Juliana , Vogt Deborah , Fassnacht Martin , Winzeler Bettina , Refardt Julie , Christ-Crain Mirjam

Introduction: Distinguishing arginine vasopressin deficiency (AVP-D, central diabetes insipidus) from primary polydipsia (PP) is challenging. The method with the highest diagnostic accuracy, hypertonic saline-stimulated copeptin, is often limited to experienced hospitals, requires close monitoring, and may be cumbersome for patients. A standardised, validated stepwise assessment and probability score to rule out AVP-D in the initial baseline evaluation is currently lacking.</p...

ea0099p549 | Pituitary and Neuroendocrinology | ECE2024

Effects of glucagon-like peptide-1 analogs on prolactin: a randomized, double-blind, placebo-controlled crossover trial

Muller Cyrill , Lengsfeld Sophia , Probst Leila , Baur Fabienne , Yara Emara , Werlen Laura , Vogt Deborah , Bathelt Cemile , Winzeler Bettina

Background: Research indicates that prolactin, a hormone linked to lactation, may influence the brain’s reward system by interacting with dopamine. GLP-1 analogues, prescribed for diabetes and obesity, are known for their appetite-suppressant effects. With GLP-1 receptors found in mood and reward-related brain regions, a potential role of GLP-1 in reward regulation is suggested. A knowledge gap exists regarding the interaction between GLP-1 and prolactin in the context of...

ea0081p165 | Pituitary and Neuroendocrinology | ECE2022

Effects of the SGLT2-inhibitor empagliflozin in patients with chronic syndrome of inadequate antidiuresis (SIAD) - results of a double-blind, randomized, placebo-controlled, crossover trial

Refardt Julie , Imber Cornelia , Nobbenhuis Rianne , Clara Odilia Sailer , Haslbauer Aaron , Vogt Deborah , Berres Manfred , Winzeler Bettina , Bridenbaugh Stephanie , Mirjam Christ-Crain

Introduction: Hyponatremia is the most common electrolyte disorder and the syndrome of inappropriate antidiuresis (SIAD) is one of its main causes. However, treatment options for chronic SIAD-induced hyponatremia are inadequate. This is problematic because hyponatremia has been associated with neurocognitive deficits, although there is little data on its reversibility. We previously showed that the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin is a promising s...

ea0090p69 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Effects of Glucagon-Like Peptide-1 Analogs on Sexual Desire: A randomized, double-blind, placebo-controlled crossover trial

Lengsfeld Sophia , Hasenbohler Flavia , Probst Leila , Baur Fabienne , Emara Yara , Bathelt Cemile , Werlen Laura , Vogt Deborah , Caviezel Brida , Vukajlovic Tanja , Christ-Crain Mirjam , Winzeler Bettina

Background: GLP-1 analogs are prescribed for diabetes and obesity due to their well-known insulinotropic, satiation-promoting and appetite-suppressant effects. Several studies also investigated the effects of GLP-1 analogs on reward to addictive drugs such as alcohol, nicotine and cocaine. Pre-clinical studies suggest that sexual desire, as another type of natural reward, could also be affected by GLP-1 analogs. Since sexuality is a very important aspect of human wellbeing and...

ea0063oc13.2 | Anterior and Posterior pituitary 2 | ECE2019

Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion – a randomized, double-blind, placebo-controlled trial

Refardt Julie , Imber Cornelia , Sailer Clara O , Jeanloz Nica , Potasso Laura , Kutz Alexander , Widmer Andrea , Urwyler Sandrine , Ebrahimi Fahim , Vogt Deborah R , Winzeler Bettina , Christ-Crain Mirjam

Introduction: The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the predominant cause of hyponatremia but the available treatment options are unsatisfying and often of little efficiency. The selective sodium-glucose co-transporter 2 inhibitor empagliflozin promotes osmotic diuresis due to glucosuria and might be a novel treatment option for SIADH.Material and methods: From September 2016 through December 2018 we randomly assigned 88...

ea0037gp.01.01 | Adrenal | ECE2015

Low-dose ACTH testing does not predict treatment response to corticosteroids in community-acquired pneumonia

Blum Claudine A , Schuetz Philipp , Nigro Nicole , Winzeler Bettina , Arici Birsen , Refardt Julie , Urwyler Sandrine A , Briel Matthias , Mueller Beat , Christ-Crain Mirjam

Background: It is controversial whether the attenuated increase of circulating cortisol to ACTH stimulation predicts treatment response to corticosteroids in patients with critical illness. We investigated whether ACTH testing predicts treatment response to corticosteroids in patients with community-acquired pneumonia (CAP).Methods: We performed a low dose (1 μg) ACTH test on admission in a prospective randomised, double-blind, placebo-controlled mu...